Madrigal Pharmaceuticals (MDGL)
(Delayed Data from NSDQ)
$193.33 USD
-1.05 (-0.54%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $192.63 -0.70 (-0.36%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Earnings Date | *BMO5/7/24 |
---|---|
Current Quarter | -6.06 |
EPS Last Quarter | -5.68 |
Last EPS Surprise | -6.77% |
ABR | 1.47 |
Earnings ESP
|
-0.76% |
---|---|
Current Year | -21.86 |
Next Year | -13.98 |
EPS (TTM) | -19.94 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | 5.30M | 84.88M | 315.76M |
# of Estimates | NA | 3 | 7 | 7 |
High Estimate | NA | 7.60M | 108.30M | 509.00M |
Low Estimate | NA | 1.30M | 61.00M | 153.08M |
Year ago Sales | 0.00M | 0.00M | NA | 84.88M |
Year over Year Growth Est. | NA | NA | NA | 272.00% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -6.06 | -5.97 | -21.86 | -13.98 |
# of Estimates | 8 | 6 | 9 | 9 |
Most Recent Consensus | -6.52 | -6.44 | -24.67 | -18.14 |
High Estimate | -4.86 | -5.45 | -13.67 | -3.72 |
Low Estimate | -6.81 | -6.98 | -26.98 | -23.82 |
Year ago EPS | -4.23 | -4.69 | -19.99 | -21.86 |
Year over Year Growth Est. | -43.26% | -27.29% | -9.35% | 36.05% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 2 | 3 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 6 | 4 | 5 | 6 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -6.06 | -5.97 | -21.86 | -13.98 |
7 Days Ago | -6.06 | -5.97 | -21.48 | -13.50 |
30 Days Ago | -6.06 | -5.97 | -21.48 | -13.50 |
60 Days Ago | -4.63 | -4.87 | -17.66 | -0.63 |
90 Days Ago | -4.01 | -4.26 | -15.33 | -0.63 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -6.11 | -5.97 | -24.89 | -17.86 |
Zacks Consensus Estimate | -6.06 | -5.97 | -21.86 | -13.98 |
Earnings ESP | -0.76% | 0.00% | -13.85% | -27.75% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -5.68 | -5.34 | -4.69 | -4.23 | NA |
Estimate | -5.32 | -4.78 | -4.47 | -4.98 | NA |
Difference | -0.36 | -0.56 | -0.22 | 0.75 | -0.10 |
Surprise | -6.77% | -11.72% | -4.92% | 15.06% | -2.09% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more